238 related articles for article (PubMed ID: 29873274)
1. STAT3: a multifaceted oncoprotein.
Guanizo AC; Fernando CD; Garama DJ; Gough DJ
Growth Factors; 2018 Apr; 36(1-2):1-14. PubMed ID: 29873274
[TBL] [Abstract][Full Text] [Related]
2. Nucleus, Mitochondrion, or Reticulum? STAT3 à La Carte.
Avalle L; Poli V
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30231582
[TBL] [Abstract][Full Text] [Related]
3. Perspectives Regarding the Intersections between STAT3 and Oxidative Metabolism in Cancer.
Chun KS; Jang JH; Kim DH
Cells; 2020 Sep; 9(10):. PubMed ID: 33003453
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial STAT3: Powering up a potent factor.
Garama DJ; White CL; Balic JJ; Gough DJ
Cytokine; 2016 Nov; 87():20-5. PubMed ID: 27269970
[TBL] [Abstract][Full Text] [Related]
5. Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.
Fletcher S; Drewry JA; Shahani VM; Page BD; Gunning PT
Biochem Cell Biol; 2009 Dec; 87(6):825-33. PubMed ID: 19935868
[TBL] [Abstract][Full Text] [Related]
6. STAT3 in cancer: A double edged sword.
Avalle L; Camporeale A; Camperi A; Poli V
Cytokine; 2017 Oct; 98():42-50. PubMed ID: 28579221
[TBL] [Abstract][Full Text] [Related]
7. Role of STAT3 in in vitro transformation triggered by TRK oncogenes.
Miranda C; Fumagalli T; Anania MC; Vizioli MG; Pagliardini S; Pierotti MA; Greco A
PLoS One; 2010 Mar; 5(3):e9446. PubMed ID: 20209132
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW; Chung HK; Park KC; Hwang JH; Jo YS; Chung J; Kalvakolanu DV; Resta N; Shong M
Mol Endocrinol; 2007 Dec; 21(12):3039-49. PubMed ID: 17761947
[TBL] [Abstract][Full Text] [Related]
9. The role of STAT3 in autophagy.
You L; Wang Z; Li H; Shou J; Jing Z; Xie J; Sui X; Pan H; Han W
Autophagy; 2015; 11(5):729-39. PubMed ID: 25951043
[TBL] [Abstract][Full Text] [Related]
10. The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations.
Geiger JL; Grandis JR; Bauman JE
Oral Oncol; 2016 May; 56():84-92. PubMed ID: 26733183
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Transcriptional Activity and Mitochondrial Localization of STAT3 Co-induce Axon Regrowth in the Adult Central Nervous System.
Luo X; Ribeiro M; Bray ER; Lee DH; Yungher BJ; Mehta ST; Thakor KA; Diaz F; Lee JK; Moraes CT; Bixby JL; Lemmon VP; Park KK
Cell Rep; 2016 Apr; 15(2):398-410. PubMed ID: 27050520
[TBL] [Abstract][Full Text] [Related]
12. Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling.
Kim M; Morales LD; Jang IS; Cho YY; Kim DJ
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208623
[TBL] [Abstract][Full Text] [Related]
13. STAT3 Post-Translational Modifications Drive Cellular Signaling Pathways in Prostate Cancer Cells.
Cocchiola R; Rubini E; Altieri F; Chichiarelli S; Paglia G; Romaniello D; Carissimi S; Giorgi A; Giamogante F; Macone A; Perugia G; Gurtner A; Eufemi M
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013746
[TBL] [Abstract][Full Text] [Related]
14. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
15. STAT3 as a mediator of oncogenic cellular metabolism: Pathogenic and therapeutic implications.
Tošić I; Frank DA
Neoplasia; 2021 Dec; 23(12):1167-1178. PubMed ID: 34731785
[TBL] [Abstract][Full Text] [Related]
16. The Ying and Yang of STAT3 in Human Disease.
Vogel TP; Milner JD; Cooper MA
J Clin Immunol; 2015 Oct; 35(7):615-23. PubMed ID: 26280891
[TBL] [Abstract][Full Text] [Related]
17. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment.
Kim BH; Yi EH; Ye SK
Arch Pharm Res; 2016 Aug; 39(8):1085-99. PubMed ID: 27515050
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
Setsu N; Kohashi K; Endo M; Yamamoto H; Tamiya S; Takahashi Y; Yamada Y; Ishii T; Matsuda S; Yokoyama R; Iwamoto Y; Oda Y
Int J Cancer; 2013 Jan; 132(1):109-15. PubMed ID: 22644781
[TBL] [Abstract][Full Text] [Related]
20. The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells.
Linher-Melville K; Singh G
Mol Cell Endocrinol; 2017 Aug; 451():40-52. PubMed ID: 28202313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
